(Last updated : 2022-05-24 14:36:49)
  永坂 岳司
   Department     ,
   Position   Associate Professor
■ BooK
1. 2020/08/25   Immunotherapy for Lynch Syndrome Patients, Lynch Syndrome: Molecular Mechanism and Current Clinical Practice 
■ Journal
1. 2022/05 Phase 3 trial of sequential versus combination treatment in colorectal cancer: The C-cubed study  Link
2. 2021/11/27 Technique of vessel-skeletonized parenchyma-sparing hepatectomy for the oncological treatment of bilobar colorectal liver metastases  Link
3. 2021/11 Concordance of acquired mutations between metastatic lesions and liquid biopsy in metastatic colorectal cancer  Link
4. 2021/05 Clinical and epigenetic features of colorectal cancer patients with somatic POLE proofreading mutations  Link
5. 2021/02 A phase II study of FOLFOXIRI plus bevacizumab as initial chemotherapy for patients with untreated metastatic colorectal cancer: TRICC1414 (BeTRI)  Link
Display all(31)
■ Presentation
1. 2022/02/17 A Phase III trial of sequential versus combination in metastatic colorectal cancer: C-Cubed study  
2. 2022/02/17 Fluctuating PD-1 ratio in blood may predict clinical outcome of upper gastrointestinal cancer patients under ICI therapy  
3. 2022/01/21 A randomized phase 3 study of sequential versus combination treatment in first-line chemotherapy for metastatic colorectal cancer: The C-cubed study  
4. 2021/11/12 Validation and development of the diagnostic technology for Lynch syndrome exclusion by a DNA
chip detecting MLH1 methylation and BRAF V600E mutations in colorectal cancer  
5. 2021/10/02 遺伝性がん 日本におけるリンチ症候群の遺伝学的・臨床的特徴  
Display all(18)